共有 2 页
| 品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|
| 罗恩 | R031973-10mg | 10mg | 5~7个工作日 |
(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,... (3R,4S)-Tofacitini |
98% |
|
|
| 阿拉丁 | T126415-10mg | 10mg | 现货 |
(3R,4S)-托法替尼 (3R,4S)-Tofacitini |
≥98% |
|
|
| 阿拉丁 | T126415-50mg | 50mg | 期货,请咨询 |
(3R,4S)-托法替尼 (3R,4S)-Tofacitini |
≥98% |
|
|
| 阿拉丁 | T126415-5mg | 5mg | 期货,请咨询 |
(3R,4S)-托法替尼 (3R,4S)-Tofacitini |
≥98% |
|
|
| 凯为 | JZ008U9E-10mg | 10mg | 现货 |
(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,... (3R,4S)-4-Methyl-3-(methyl-7... |
98% |
|
|
| 凯为 | JZ008U9E-25mg | 25mg | 现货 |
(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,... (3R,4S)-4-Methyl-3-(methyl-7... |
98% |
|
|
| 凯为 | JZ008U9E-50mg | 50mg | 现货 |
(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,... (3R,4S)-4-Methyl-3-(methyl-7... |
98% |
|
|
| 凯为 | JZ008U9E-1mg | 1mg | 现货 |
(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,... (3R,4S)-4-Methyl-3-(methyl-7... |
98% |
|
|
| 凯为 | JZ008U9E-5mg | 5mg | 现货 |
(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,... (3R,4S)-4-Methyl-3-(methyl-7... |
98% |
|
|
| 毕得 | BD491021-5mg | 5mg | 现货 |
3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并... 3-((3R,4S)-4-Methyl-3-(methy... |
98% |
|
|
| 毕得 | BD491021-1mg | 1mg | 现货 |
3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并... 3-((3R,4S)-4-Methyl-3-(methy... |
98% |
|
|
| 毕得 | BD491021-50mg | 50mg | 现货 |
3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并... 3-((3R,4S)-4-Methyl-3-(methy... |
98% |
|
|
| 毕得 | BD491021-25mg | 25mg | 现货 |
3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并... 3-((3R,4S)-4-Methyl-3-(methy... |
98% |
|
|
| 毕得 | BD491021-10mg | 10mg | 现货 |
3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并... 3-((3R,4S)-4-Methyl-3-(methy... |
98% |
|
|
| TRC | T528000-10mg | 10mg | 期货,请咨询 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
|
|
|
| TRC | T528000-1mg | 1mg | 期货,请咨询 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
|
|
|
| TRC | T528000-2.5mg | 2.5mg | 期货,请咨询 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
|
|
|
| solarbio | IYT2387-1mg | 1mg | 请咨询 | (3R,4S)-托法替尼 |
|
|
|
| solarbio | IYT2387-5mg | 5mg | 请咨询 | (3R,4S)-托法替尼 |
|
|
|
| 安耐吉 | M0133252-100mg | 100mg | 现货 |
3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并... 3-((3R,4S)-4-Methyl-3-(methy... |
97% |
|
|
| 安耐吉 | M0133252-25mg | 25mg | 现货 |
3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并... 3-((3R,4S)-4-Methyl-3-(methy... |
97% |
|
|
| 安耐吉 | M0133252-5mg | 5mg | 现货 |
3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并... 3-((3R,4S)-4-Methyl-3-(methy... |
97% |
|
|
| 源叶 | B58036-10mg | 10mg | 期货,请咨询 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
98% |
|
|
| 源叶 | V34916-10mg | 10mg | 现货 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
≥98% |
|
|
| 源叶 | V34916-50mg | 50mg | 现货 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
≥98% |
|
|
| QCC | QT060315 | 100mg | 4-6周 |
Tofacitinib Impurity O Tofacitinib Impurity O |
咨询 | 请联系客服购买! | |
| MCE | HY-40354D-10mg | 10mg | 现货 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
99.88% |
|
|
| MCE | HY-40354D-5mg | 5mg | 现货 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
99.88% |
|
|
| MCE | HY-40354D-1mg | 1mg | 现货 |
(3R,4S)-Tofacitinib (3R,4S)-Tofacitini |
99.88% |
|
|